HMGA2 and leiomyoma: No significant difference was seen in the number of HMGA2 overexpressing tumors between histopathological UL variants (13.8%, 13/94) and conventional leiomyomas (Table 1, see Additional file 5: Table S2 and Additional file 6: Table S3).